Dahuang Zhechong Pill Improves Pulmonary Fibrosis through miR-29b-2-5p/HK2 Mediated Glycolysis Pathway
Chinese Journal of Integrative Medicine · 2025-07 · 31 (7) · 600-612
DOI: 10.1007/s11655-024-3765-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, online erschienen am 05.09.2024. Verfasst von Xiao-Yan He und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Hauptthemen laut MEDLINE: MicroRNAs, Glycolysis, Pulmonary Fibrosis, Drugs, Chinese Herbal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To explore the preventive and therapeutic effects of Dahuang Zhechong Pill (DZP) on pulmonary fibrosis and the underlying mechanisms. METHODS: The first key rate-limiting enzyme hexokinase 2 (HK2) of glycolysis was silenced and over-expressed through small interfering RNA and lentivirus using lung fibroblast MRC-5 cell line, respectively. The cell viability, migration, invasion and proliferation were detected by cell counting kit-8, wound healing assay, transwell assay, and flow cytometry. The mRNA and protein expression levels of HK2 were detected by RT-PCR and Western blotting, respectively. The contents of glucose, adenosine triphosphate (ATP) and lactate in MRC-5 cells were determined by enzyme-linked immunosorbnent assay (ELISA). Then, the relationship between miR-29b-2-5p and HK2 was explored by luciferase reporter gene assay. Pulmonary fibrosis cell model was induced by transforming growth factor-β 1 (TGF-β 1) in MRC-5 cells, and the medicated serum of DZP (DMS) was prepared in rats. MRC-5 cells were divided into control, TGF-β 1, TGF-β 1+10% DMS, TGF-β 1+10% DMS+miR-29b-2-5p inhibitor, TGF-β 1+10% DMS+inhibitor negative control, TGF-β 1+10% DMS+miR-29b-2-5p mimic and TGF-β 1+10% DMS+mimic negative control groups. After miR-29b-2-5p mimics and inhibitors were transfected into MRC-5 cells, all groups except control and model group were treated with DMS. The effect of DMS on MRC-5 cells were detected using aforementioned methods and immunofluorescence. Similarly, the contents of glucose, ATP and lactate in each group were measured by ELISA. RESULTS: The mRNA and protein expressions of HK2 in MRC-5 cells were successfully silenced and overexpressed through si-HK2-3 and lentiviral transfection, respectively. After silencing HK2, the mRNA and protein expressions of HK2 were significantly decreased (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- Department of Neurology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
- College of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. wulijuan@cdutcm.edu.cn.
Zitieren
APA
He, X. Y., Liang, J. T., Xiao, J. Y., Li, X., Zhang, X. B., Chen, D. Y., & Wu, L. J. (2025). Dahuang Zhechong Pill Improves Pulmonary Fibrosis through miR-29b-2-5p/HK2 Mediated Glycolysis Pathway. Chinese Journal of Integrative Medicine, 31(7), 600-612. https://doi.org/10.1007/s11655-024-3765-x
Vancouver
He XY, Liang JT, Xiao JY, Li X, Zhang XB, Chen DY, et al. Dahuang Zhechong Pill Improves Pulmonary Fibrosis through miR-29b-2-5p/HK2 Mediated Glycolysis Pathway. Chinese Journal of Integrative Medicine. 2025;31(7):600-612. doi:10.1007/s11655-024-3765-x
BibTeX
@article{He2025,
author = {He, Xiao-Yan and Liang, Jing-Tao and Xiao, Jing-Yi and Li, Xin and Zhang, Xiao-Bo and Chen, Da-Yi and Wu, Li-Juan},
title = {Dahuang Zhechong Pill Improves Pulmonary Fibrosis through miR-29b-2-5p/HK2 Mediated Glycolysis Pathway},
journal = {Chinese Journal of Integrative Medicine},
year = {2025},
volume = {31},
number = {7},
pages = {600--612},
doi = {10.1007/s11655-024-3765-x}
}
EUVIMED